Loading...

Home
ETF
CLNN

CLNN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CLNN News

Clene Inc. to Present at Emerging Growth Conference on January 21, 2026

Jan 16 2026Globenewswire

Clene Inc. to Present at Emerging Growth Conference on January 21, 2026

Jan 16 2026Newsfilter

China SXT Pharmaceuticals (SXTC) Closes $10 Million Offering, Stock Rises 17.4%

Jan 14 2026NASDAQ.COM

Clene Inc. Receives FDA Approval for In-Person Meeting in 2026, NfL Reductions Linked to Lower ALS Mortality Risk

Jan 12 2026Globenewswire

Clene Inc. Receives FDA Approval for In-Person Meeting in 2026, NfL Reduction Significantly Lowers ALS Mortality Risk

Jan 12 2026Newsfilter

Clene Inc. Secures $28 Million Financing to Advance ALS Drug Development

Jan 09 2026Globenewswire

Clene Insider Offloads Shares Valued at $1,725,735, Per Recent SEC Filing

Dec 18 2025Yahoo Finance

88th Emerging Growth Conference Scheduled for December 10-11, 2025

Dec 10 2025Globenewswire

Clene Set to Deliver Important Update on CNM-Au8 for Amyotrophic Lateral Sclerosis

Dec 03 2025NASDAQ.COM

Biotech Stocks Rise After Hours: Clene Jumps Ahead of ALS Update; Werewolf, Biomea, and Dyne Also Gain

Dec 03 2025NASDAQ.COM

Clene Inc. to Update ALS Treatment Progress on December 3, 2025

Dec 02 2025Globenewswire

Clene Inc. to Update ALS Treatment Progress on December 3, 2025

Dec 02 2025Newsfilter

D. Boral Capital Reiterates Buy Rating on Clene with $23 Price Target Intact

Nov 17 2025Benzinga

D. Boral Capital Reiterates Buy Rating on Clene with $23 Price Target Intact

Oct 24 2025Benzinga

Clene Unveils New Clinical Findings at ECTRIMS 2025 Meeting Showing CNM-Au8® Enhances Brain Energy Metabolism in Patients with Multiple Sclerosis

Sep 25 2025Newsfilter

Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open

Aug 18 2025Globenewswire